Design and methods of the Raloxifene Use for The Heart (RUTH) study

This publication has 13 references indexed in Scilit:

• Awareness, Perception, and Knowledge of Heart Disease Risk and Prevention Among Women in the United States
  Archives of Family Medicine, 2000
• A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium
  Obstetrics & Gynecology, 2000
• The Potential of SERMs for Reducing the Risk of Coronary Heart Disease
  Trends in Endocrinology & Metabolism, 1999
• Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical Trial
  JAMA, 1999
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Design of the Women’s Health Initiative Clinical Trial and Observational Study
  Controlled Clinical Trials, 1998
• Medroxyprogesterone Acetate Antagonizes Inhibitory Effects of Conjugated Equine Estrogens on Coronary Artery Atherosclerosis
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Sample size calculation for complex clinical trials with survival endpoints
  Controlled Clinical Trials, 1995
• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
  JAMA, 1995
• Sample size determination in clinical trials with time-dependent rates of losses and noncompliance
  Controlled Clinical Trials, 1986